# Low-Dose Risperidone Treatment for Subjects Suffering From Borderline Personality Disorder

> **NCT00633802** · NA · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Borderlone Personality Disorder

## Interventions

- **DRUG:** Risperidone

## Key facts

- **NCT ID:** NCT00633802
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-04
- **Primary completion:** 2009-04
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2008-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00633802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00633802, "Low-Dose Risperidone Treatment for Subjects Suffering From Borderline Personality Disorder". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00633802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*